BRD2 and colorectal carcinoma: We found that the NAT expression of miR-509-3p in CRC shows a strong statistically significant separation between patients showing poor prognosis versus good prognosis with an Area Under Curve (AUC) of 0.7453 (95% CI: 0.6467–0.8439, p < 0.0001) (Fig. 6H).